PCR arrays

LGC said that the acquisition will increase its presence in the nucleic acid market, in addition to its previous acquisitions in the last few years.

The firm sees the new panel as an important step forward in its strategy to further penetrate the molecular diagnostics market with its qPCR products.

In counting defective proviruses, approaches for estimating the size of HIV patients' virus reservoirs are throwing off estimates of treatment effectiveness.

LGC said it plans to use Douglas Scientific's PCR and qPCR platforms to provide customers with enhanced high-throughput genotyping and qPCR instruments.

Available in March, the PCR-based FilmArray 2.0 platform has higher throughput and takes up a smaller footprint.

NEW YORK (GenomeWeb News) – A study online today in the Journal of Clinical Investigation suggests cigarette smoke may exert some of its negative, cancer-promoting effects through an epigenetic pathway that curtails the activity of a microRNA called miR-487b.

Akonni Biosystems and Albany, NY-based Wadsworth Center are working together under a $300,000 National Institutes of Health grant to develop a closed amplicon PCR microarray to detect encephalitis- and meningitis-causing viruses in cerebral spinal fluid, Akonni said this week.

The companies have partnered to offer more than 100 pathway-focused gene expression panels validated for real-time PCR analysis on Fluidigm's BioMark system.

While Qiagen is primarily interested in SABiosciences' PCR Arrays and bioinformatics tools, the company also offers a number of microarray resources, including its own line of focused gene-expression arrays, a menu of reagent kits, data-analysis software, and core services on the Agilent Technologies and Illumina platforms.

Qiagen’s goal is to enable its customers to take an assay in a very early stage of discovery and validation and, “without transitioning platforms — to seamlessly move that into a companion diagnostic candidate if they so wish."

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.